Jonathan Shuter1, Steven L Bernstein, Alyson B Moadel. 1. AIDS Center and Division of Infectious Diseases, Montefiore Medical Center and the Albert Einstein College of Medicine, Bronx, NY, USA. jshuter@montefiore.org
Abstract
OBJECTIVE: To measure biopsychosocial domains related to tobacco use in persons living with HIV/AIDS (PLWHAs). METHODS: Cross-sectional interview study of 60 PLWHA smokers randomly selected from an HIV clinic. RESULTS: Participants averaged 14.4 cigarettes daily. Sixty-five percent were moderately or highly nicotine dependent, and most were motivated to quit. Substance use and depression were very common. Most reported that smoking helped them cope with depression, anxiety, and anger. Twenty-seven percent thought (mistakenly) that smoking raised their T-cell counts and/or helped fight infections. Referrals to quitlines or cessation programs were uncommon. CONCLUSIONS: Smoking among PLWHAs is a challenging problem requiring targeted intervention strategies.
OBJECTIVE: To measure biopsychosocial domains related to tobacco use in persons living with HIV/AIDS (PLWHAs). METHODS: Cross-sectional interview study of 60 PLWHA smokers randomly selected from an HIV clinic. RESULTS:Participants averaged 14.4 cigarettes daily. Sixty-five percent were moderately or highly nicotine dependent, and most were motivated to quit. Substance use and depression were very common. Most reported that smoking helped them cope with depression, anxiety, and anger. Twenty-seven percent thought (mistakenly) that smoking raised their T-cell counts and/or helped fight infections. Referrals to quitlines or cessation programs were uncommon. CONCLUSIONS: Smoking among PLWHAs is a challenging problem requiring targeted intervention strategies.
Authors: Jack E Burkhalter; Carolyn M Springer; Rosy Chhabra; Jamie S Ostroff; Bruce D Rapkin Journal: Nicotine Tob Res Date: 2005-08 Impact factor: 4.244
Authors: Kristina Crothers; Tephany A Griffith; Kathleen A McGinnis; Maria C Rodriguez-Barradas; David A Leaf; Sharon Weissman; Cynthia L Gibert; Adeel A Butt; Amy C Justice Journal: J Gen Intern Med Date: 2005-12 Impact factor: 5.128
Authors: A C Moorman; S D Holmberg; S I Marlowe; J C Von Bargen; B G Yangco; F J Palella; D J Ward; M O Loveless; J Fuhrer; P Joseph; W A Alexander; D J Aschman Journal: Ann Epidemiol Date: 1999-08 Impact factor: 3.797
Authors: D N Burns; D Hillman; J D Neaton; R Sherer; T Mitchell; L Capps; W G Vallier; M D Thurnherr; F M Gordin Journal: J Acquir Immune Defic Syndr Hum Retrovirol Date: 1996-12-01
Authors: Jonathan Shuter; Alyson B Moadel; Ryung S Kim; Andrea H Weinberger; Cassandra A Stanton Journal: Nicotine Tob Res Date: 2014-08-23 Impact factor: 4.244
Authors: Karen L Cropsey; Bianca F Jardin; Greer A Burkholder; C Brendan Clark; James L Raper; Michael S Saag Journal: J Acquir Immune Defic Syndr Date: 2015-07-01 Impact factor: 3.731
Authors: Alyson B Moadel; Steven L Bernstein; Robin J Mermelstein; Julia H Arnsten; Eileen H Dolce; Jonathan Shuter Journal: J Acquir Immune Defic Syndr Date: 2012-10-01 Impact factor: 3.731
Authors: Andrea H Weinberger; Philip H Smith; Allison P Funk; Shayna Rabin; Jonathan Shuter Journal: J Acquir Immune Defic Syndr Date: 2017-04-01 Impact factor: 3.731
Authors: Andrea H Weinberger; Elizabeth K Seng; Joseph W Ditre; Melody Willoughby; Jonathan Shuter Journal: Nicotine Tob Res Date: 2019-03-30 Impact factor: 4.244
Authors: Conall O'Cleirigh; Sarah E Valentine; Megan Pinkston; Debra Herman; C Andres Bedoya; Janna R Gordon; Steven A Safren Journal: AIDS Behav Date: 2015-01